- Education
-
Research
Current research
Talent
-
Collaboration
Businesses
Government agencies and institutions
Alumni
-
About AU
Organisation
Job at AU
With a grant of DKK 25 million from the Novo Nordisk Foundation, Professor Jens Otto Lunde Jørgensen from the Department of Clinical Medicine is one of the researchers charged with generating knowledge about how to detect and remedy side effects after long-term treatment with corticosteroid therapy.
2021.04.08 |
Professor Jens Otto Lunde Jørgensen is one of the researchers charged with generating knowledge on long-term treatment with corticosteroid therapy. Photo: Novo Nordisk Fonden
Approximately three per cent of the Danish population annually undergoes treatment with corticosteroids, for example with the medicinal product Prednisolon. The treatment itself has significant side effects, while discontinuation of the steroid treatment can trigger symptoms of adrenocorticotropic hormone deficiency. Nevertheless, according to Jens Otto Lunde, who is also a consultant at Aarhus University Hospital, there are no dedicated studies of the side effects of the treatment.
He will now work together with researchers from all over the country to establish ‘the gold standard' for treatment with corticosteroids, which have been extensively used in the healthcare system for almost seventy-five years. The project will culminate in the first evidence-based guidelines for the diagnosis and treatment of side effects associated with treatment with corticosteroid therapy, and the Novo Nordisk Foundation is supporting the research project with DKK 25 million.
Professor, Department Chair & Consultant Jens Otto Lunde Jørgensen
Aarhus University, Department of Clinical Medicine and
Aarhus University Hospital, Department of Endocrinology and Internal Medicine
Mobile: (+45) 2072 7383
Email: joj@clin.au.dk
This coverage is based on press material from Aarhus University Hospital.